IP Library › Assignment 014446/0312
Patent Assignment
Reel/Frame 014446/0312

Release of Security Agreement

Recorded: 2004-03-19 Pages: 8
Assignor
SILICON VALLEY BANK
Executed: 2004-02-04
Assignee
CONNETICS CORPORATION
3290 WEST BAYSHORE RD., PALO ALTO, CALIFORNIA, 94303
Covered Properties (49)
Peptides with Relaxin Activity
Patent: 4,656,249 →
Application: 06/387,131 →
Molecular Cloning and Characterization of a Gene Sequence Coding for Human Relaxin
Application: 06/522,956 →
Molecular Cloning and Characterization of a Further Gene Sequence Coding for Human Relaxin
Patent: 4,758,516 →
Application: 06/560,790 →
Molecular Cloning and Characterization of a Gene Sequence Coding for Human Relaxin
Patent: 4,871,670 →
Application: 06/863,819 →
Method of Chain Combination
Patent: 4,835,251 →
Application: 06/877,819 →
Molecular Cloning and Characterization of a Gene Sequence Coding for Human Relaxin
Application: 07/021,878 →
Molecular Cloning and Characterization of a Further Gene Sequence Coding for Human Relaxin
Patent: 5,023,321 →
Application: 07/021,885 →
Human Relaxin Formulation
Application: 07/160,797 →
Human Relaxin Formulation
Application: 07/303,779 →
Temporal Gamma-Interferon Administration for Allergies
Patent: 5,112,605 →
Application: 07/325,406 →
Processes and Compositions for the Isolation of Human Relaxin
Application: 07/347,550 →
Anti-Autoimmune Disease Vaccines and Therapeutics
Application: 07/382,804 →
T Cell Receptor Peptides as Therapeutics or Autoimmue and Malignant Disease
Application: 07/467,577 →
Gamma Interferon Formulation
Patent: 5,151,265 →
Application: 07/514,392 →
Molecular Cloning and Characterization of a Gene Sequence Coding for Human Relaxin
Patent: 5,053,488 →
Application: 07/549,668 →
Method of Detecting Cancer by Measuring Lipid-Peroxidation Using Nmr
Application: 07/557,529 →
Human Immune Interferon
Patent: 5,096,705 →
Application: 07/574,375 →
Human Prorelaxin Polypeptides
Patent: 5,179,195 →
Application: 07/665,129 →
Human Prorelaxin Polypeptides
Patent: 5,145,962 →
Application: 07/681,828 →
T Cell Receptor Peptides as Therapeutics for Immune-Related Disease
Application: 07/708,022 →
T Cell Receptor Peptides as Therapeutics for Immune-Related Disease
Application: 07/735,612 →
Use of Relaxin in Cardiovascular Therapy
Patent: 5,166,191 →
Application: 07/747,080 →
Temporal Gamma-Interferon Administration for Allergies
Patent: 5,196,191 →
Application: 07/774,429 →
Process for Sythesizing Human H2-Prorelaxin, Human H2-Relaxin and Fusi on Proteins Thereof
Patent: 5,326,694 →
Application: 07/871,318 →
Use of Relaxin in the Treatment of Bradycardia
Patent: 5,478,807 →
Application: 07/902,637 →
Processes and Compositions for the Isolation of Human Relaxin
Patent: 5,464,756 →
Application: 07/908,766 →
Treatment of Atopic Disorders with Gamma-Interferon
Patent: 5,200,177 →
Application: 07/912,564 →
Process for Synthesizing Human H1-Prorelaxin, H1-Relaxin and Fusion Pr Oteins Thereof
Patent: 5,320,953 →
Application: 07/921,090 →
Human Relaxin Formulation
Patent: 5,451,572 →
Application: 08/050,745 →
T Cell Receptor Peptides as Therapeutics for Immune-Related Disease
Patent: 5,614,192 →
Application: 08/059,020 →
Process for Producing Relaxin
Application: 08/080,354 →
Recombinant Des-Cys-Tyr-Cys Human Immune Interferon
Patent: 5,582,824 →
Application: 08/150,772 →
Recombinant Gamma Interferons Having Enhanced Stability and Methods Therefor
Patent: 5,690,925 →
Application: 08/216,511 →
Methods for Diagnosing an Immune-Related Disease and Choosing an Immune-Related Therapy
Application: 08/270,634 →
Process for Producing Relaxin
Patent: 5,759,807 →
Application: 08/443,568 →
Treatment for Systemic Lupus Erythematosus
Patent: 5,679,651 →
Application: 08/461,391 →
Human Relaxin Formulation
Patent: 5,945,402 →
Application: 08/471,920 →
Yethod of Treatment for Depression
Patent: 5,753,623 →
Application: 08/475,004 →
Tcr V Beta 5 Peptides
Patent: 5,776,459 →
Application: 08/476,405 →
Relaxin Analogs and Derivatives Methods and Uses Thereof
Patent: 5,811,395 →
Application: 08/483,476 →
Relaxin-Like Factor and Methods and Uses Thereof
Patent: 5,911,997 →
Application: 08/484,219 →
Treating Immune Deficiency Diseases
Application: 08/486,966 →
Relaxin Diagnostic Assays and Kits, and Methods and Uses Thereof
Application: 08/488,399 →
Method of Promoting Angiogenesis Using Relaxin
Patent: 6,211,147 →
Application: 08/698,359 →
Method of Treating a Skin Disease with a Corticosteroid- Containing Pharmaceutical Composition
Patent: 6,126,920 →
Application: 08/913,144 →
Relaxin-Like Factor and Methods and Uses Thereof
Application: 09/041,491 →
Relaxin Analogs and Derivatives Methods and Uses Thereof
Patent: 6,200,953 →
Application: 09/158,706 →
Linear Antigen Supporting Units
Patent: 6,582,700 →
Application: 09/191,904 →
Method of Promoting Angiogenesis
Application: 60/002,355 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Jan 9, 2002
From: IMMINE RESPONSE CORPORATION, THE
To: KEVIN KIMBERLIN PARTNERS, L.P.
Reel/Frame 012418/0730 →
Assignment of Assignor's Interest Jan 20, 2004
From: CONNETICS CORPORATION
To: BAS MEDICAL, INC.
Reel/Frame 014901/0382 →
Re-Record to Correct Nature of Conveyance Recorded at Reel 014901, Frame 0382 to Read --Other: Transfer of Other Interests.-- Dec 23, 2008
From: CONNECTICS CORPORATION
To: BAS MEDICAL, INC.
Reel/Frame 022024/0155 →